Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MAVRTX · Entity 2875 | Director | June 01, 2010 | June 02, 2010 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
VERTEX PHARMACEUTICALS INC / MA
Report date June 01, 2010 · Filed June 02, 2010
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $34.24 · Expires 2020-05-31 | Direct | 40,000 |
Reported balance
After 2010-06-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2010-06-01 · Grant · Acquired 40,000 · Balance 40,000 F1: Fully vested. |
Filing footnotes · ownership attribution and instrument terms
F1: Fully vested.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 07, 2007 Filed May 8, 2007 18:49 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 10,000 | $19.78 | $197,800.00 |
DisclosureSEC source: 0000875320-07-000043 · edgar.xml · nonDerivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,383 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 24, 2007 Filed Jan 26, 2007 15:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantCommon Stock | 383 | $0.01 | $3.83 |
DisclosureSEC source: 0000875320-07-000009 · edgar.xml · nonDerivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,383 Read SEC document |
| December 15, 2006 Filed Dec 18, 2006 21:49 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $38.95 | $0.00 |
DisclosureSEC source: 0000875320-06-000121 · edgar.xml · derivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 20,000 shares Expires 2016-12-14 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| December 08, 2006 Filed Dec 11, 2006 16:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 2,000 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000875320-06-000114 · edgar.xml · derivative · entry 6 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 2,000 shares Expires 2006-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1994 Stock and Option Plan. Fully vested. Read SEC document |
| December 08, 2006 Filed Dec 11, 2006 16:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 2,000 | $42.95 | $85,900.00 |
DisclosureSEC source: 0000875320-06-000114 · edgar.xml · nonDerivative · entry 4 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 08, 2006 Filed Dec 11, 2006 16:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionCommon Stock | 2,000 | $13.23 | $26,460.00 |
DisclosureSEC source: 0000875320-06-000114 · edgar.xml · nonDerivative · entry 3 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 07, 2006 Filed Dec 11, 2006 16:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000875320-06-000114 · edgar.xml · derivative · entry 5 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 102,000 Underlying: Common Stock · 3,000 shares Expires 2006-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1994 Stock and Option Plan. Fully vested. Read SEC document |
| December 07, 2006 Filed Dec 11, 2006 16:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 3,000 | $43.97 | $131,910.00 |
DisclosureSEC source: 0000875320-06-000114 · edgar.xml · nonDerivative · entry 2 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 07, 2006 Filed Dec 11, 2006 16:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionComon Stock | 3,000 | $13.23 | $39,690.00 |
DisclosureSEC source: 0000875320-06-000114 · edgar.xml · nonDerivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 06, 2006 Filed Dec 7, 2006 17:59 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000875320-06-000113 · edgar.xml · derivative · entry 3 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 3,000 shares Expires 2006-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1994 Stock and Option Plan. Fully vested. Read SEC document |
| December 06, 2006 Filed Dec 7, 2006 17:59 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 3,000 | $44.71 | $134,130.00 |
DisclosureSEC source: 0000875320-06-000113 · edgar.xml · nonDerivative · entry 2 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 06, 2006 Filed Dec 7, 2006 17:59 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionComon Stock | 3,000 | $13.23 | $39,690.00 |
DisclosureSEC source: 0000875320-06-000113 · edgar.xml · nonDerivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 05, 2006 Filed Dec 6, 2006 18:22 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000875320-06-000111 · edgar.xml · derivative · entry 3 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 108,000 Underlying: Common Stock · 3,000 shares Expires 2006-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1994 Stock and Option Plan. Fully vested. Read SEC document |
| December 05, 2006 Filed Dec 6, 2006 18:22 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 3,000 | $44.51 | $133,530.00 |
DisclosureSEC source: 0000875320-06-000111 · edgar.xml · nonDerivative · entry 2 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 05, 2006 Filed Dec 6, 2006 18:22 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionComon Stock | 3,000 | $13.23 | $39,690.00 |
DisclosureSEC source: 0000875320-06-000111 · edgar.xml · nonDerivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2006 Filed Dec 5, 2006 19:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000875320-06-000109 · edgar.xml · derivative · entry 3 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,000 Underlying: Common Stock · 3,000 shares Expires 2006-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1994 Stock and Option Plan. Fully vested. Read SEC document |
| December 04, 2006 Filed Dec 5, 2006 19:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 3,000 | $44.28 | $132,840.00 |
DisclosureSEC source: 0000875320-06-000109 · edgar.xml · nonDerivative · entry 2 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 04, 2006 Filed Dec 5, 2006 19:07 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionComon Stock | 3,000 | $13.23 | $39,690.00 |
DisclosureSEC source: 0000875320-06-000109 · edgar.xml · nonDerivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2006 Filed Dec 4, 2006 20:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000875320-06-000107 · edgar.xml · derivative · entry 3 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,000 Underlying: Common Stock · 3,000 shares Expires 2006-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1994 Stock and Option Plan. Fully vested. Read SEC document |
| December 01, 2006 Filed Dec 4, 2006 20:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 3,000 | $43.86 | $131,580.00 |
DisclosureSEC source: 0000875320-06-000107 · edgar.xml · nonDerivative · entry 2 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1. Read SEC document |
| December 01, 2006 Filed Dec 4, 2006 20:46 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionComon Stock | 3,000 | $13.23 | $39,690.00 |
DisclosureSEC source: 0000875320-06-000107 · edgar.xml · nonDerivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 30, 2006 Filed Dec 1, 2006 18:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionStock Option · Derivative | 3,000 | $0.00 Strike: $13.23 | $0.00 |
DisclosureSEC source: 0000875320-06-000105 · edgar.xml · derivative · entry 3 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 117,000 Underlying: Common Stock · 3,000 shares Expires 2006-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Right to buy under 1994 Stock and Option Plan. Fully vested. Read SEC document |
| November 30, 2006 Filed Dec 1, 2006 18:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | SaleCommon Stock | 3,000 | $44.54 | $133,620.00 |
DisclosureSEC source: 0000875320-06-000105 · edgar.xml · nonDerivative · entry 2 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 F1 · kind: Transaction made pursuant to Dr. Sanders' company approved trading plan established under Rule 10b5-1. Read SEC document |
| November 30, 2006 Filed Dec 1, 2006 18:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | Exercise / conversionComon Stock | 3,000 | $13.23 | $39,690.00 |
DisclosureSEC source: 0000875320-06-000105 · edgar.xml · nonDerivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 01, 2006 Filed Jun 2, 2006 16:52 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $34.32 | $0.00 |
DisclosureSEC source: 0000875320-06-000046 · edgar.xml · derivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 20,000 shares Expires 2016-05-31 F1 · derivative.exercise_date: Right to buy under 2006 Stock and Option Plan. Fully vested. Read SEC document |
| June 01, 2005 Filed Jun 3, 2005 15:13 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 10,000 | $0.00 Strike: $13.32 | $0.00 |
DisclosureSEC source: 0000875320-05-000032 · edgar.xml · derivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 10,000 shares Expires 2015-05-31 F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested. Read SEC document |
| June 01, 2004 Filed Jun 2, 2004 14:50 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 7,500 | $0.00 Strike: $9.09 | $0.00 |
DisclosureSEC source: 0000875320-04-000061 · edgar.xml · derivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 7,500 shares Expires 2014-05-31 F1 · derivative.exercise_date: Right to buy under 1996 Stock and Option Plan. Fully vested. Read SEC document |
| November 12, 2003 Filed Nov 12, 2003 20:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | PurchaseCommon Stock | 10,000 | $8.28 | $82,800.00 |
DisclosureSEC source: 0000875320-03-000044 · edgar.xml · nonDerivative · entry 2 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,000 Read SEC document |
| November 12, 2003 Filed Nov 12, 2003 20:55 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | PurchaseCommon Stock | 10,000 | $8.28 | $82,800.00 |
DisclosureSEC source: 0000875320-03-000044 · edgar.xml · nonDerivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,000 Read SEC document |
| June 01, 2003 Filed Jun 3, 2003 18:37 UTC | VERTEX PHARMACEUTICALS INC / MA VRTX · Entity 2875 | GrantStock Option · Derivative | 7,500 | $0.00 Strike: $14.46 | $0.00 |
DisclosureSEC source: 0000875320-03-000012 · edgar.xml · derivative · entry 1 SANDERS CHARLES A · CIK 0001022936 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,500 Underlying: Common Stock · 7,500 shares Expires 2013-05-31 F1 · derivative.exercise_date: Right to buy under the 1996 Stock and Option Plan. Fully vested. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.